Home › Duchenne Muscular Dystrophy › Arkansas
Duchenne Muscular Dystrophy clinical trials in Arkansas
6 studies for Duchenne Muscular Dystrophy are looking for participants at sites in Arkansas.
Cities in Arkansas
Duchenne Electronic Health Record Study
- Arkansas Children's Hospital, Little Rock
RecruitingObservational study
All ages · All sexes · Updated Nov 2, 2026 · NCT07609394PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 1/2
Ages 2 to 7 · Men · Updated Oct 21, 2026 · NCT07429240A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 3
Ages 7 to 11 · Men · Updated Sep 28, 2026 · NCT07160634A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 1
Ages 2 and older · Men · Updated Sep 11, 2026 · NCT04626674A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 1/2
Ages 0 to 17 · Men · Updated Jul 8, 2026 · NCT06138639A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
- Arkansas Children's Research Institute, Little Rock
RecruitingObservational study
Ages 6 and older · All sexes · Updated Jul 2, 2026 · NCT07127978From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.